Beyond Air, Inc. Cost of Revenue
Beyond Air, Inc. (XAIR) reported Cost of Revenue of $1.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- Beyond Air, Inc. cost of revenue for the quarter ending 2026-06-30 was $1.54M, a 3.80% decline year-over-year.
- Beyond Air, Inc. cost of revenue for the quarter ending 2026-03-31 was $1.81M, a 53.13% increase year-over-year.
- Beyond Air, Inc. cost of revenue for the quarter ending 2025-12-31 was $1.89M, a 47.16% increase year-over-year.
- Beyond Air, Inc. cost of revenue for the quarter ending 2025-09-30 was $2.12M, a 12.43% increase year-over-year.
- Beyond Air, Inc. cost of revenue for fiscal 2026 was $7.43M, a 38.36% increase from fiscal 2025.
- Beyond Air, Inc. cost of revenue for fiscal 2025 was $5.37M, a 117.68% increase from fiscal 2024.
- Beyond Air, Inc. cost of revenue for fiscal 2024 was $2.47M, a 344.32% increase from fiscal 2023.
- Beyond Air, Inc. cost of revenue for fiscal 2023 was $555.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.54M 10-Q · filed 2026-08-13 | $3.36M derived: sum of 2 quarters · filed 2026-08-13 | $5.25M derived: sum of 3 quarters · filed 2026-08-13 | $7.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $3.71M derived: sum of 2 quarters · filed 2026-06-26 | $5.82M derived: sum of 3 quarters · filed 2026-06-26 | $7.43M 10-K · filed 2026-06-26 |
| 2025-12-31 | $1.89M 10-Q · filed 2026-02-13 | $4.01M derived: sum of 2 quarters · filed 2026-02-13 | $5.61M 10-Q · filed 2026-02-13 | $6.80M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $2.12M 10-Q · filed 2025-11-10 | $3.72M 10-Q · filed 2025-11-10 | $4.90M derived: sum of 3 quarters · filed 2026-08-13 | $6.19M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.60M 10-Q · filed 2026-08-13 | $2.79M derived: sum of 2 quarters · filed 2026-08-13 | $4.08M derived: sum of 3 quarters · filed 2026-08-13 | $5.96M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $2.47M derived: sum of 2 quarters · filed 2026-06-26 | $4.35M derived: sum of 3 quarters · filed 2026-06-26 | $5.37M 10-K · filed 2026-06-26 |
| 2024-12-31 | $1.29M 10-Q · filed 2026-02-13 | $3.17M derived: sum of 2 quarters · filed 2026-02-13 | $4.18M 10-Q · filed 2026-02-13 | $5.17M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $1.88M 10-Q · filed 2025-11-10 | $2.90M 10-Q · filed 2025-11-10 | $3.88M derived: sum of 3 quarters · filed 2025-11-10 | $4.63M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $1.02M 10-Q · filed 2025-08-12 | $2.00M derived: sum of 2 quarters · filed 2025-08-12 | $2.75M derived: sum of 3 quarters · filed 2025-08-12 | $3.18M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $1.73M derived: sum of 2 quarters · filed 2025-06-20 | $2.16M derived: sum of 3 quarters · filed 2025-06-20 | $2.47M 10-K · filed 2025-06-20 |
| 2023-12-31 | $748.00K 10-Q · filed 2025-02-10 | $1.18M derived: sum of 2 quarters · filed 2025-02-10 | $1.48M 10-Q · filed 2025-02-10 | $1.79M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-09-30 | $432.00K 10-Q · filed 2024-11-12 | $735.00K 10-Q · filed 2024-11-12 | $1.04M derived: sum of 3 quarters · filed 2024-11-12 | $1.11M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $303.00K 10-Q · filed 2024-08-06 | $611.00K derived: sum of 2 quarters · filed 2024-08-06 | $679.00K derived: sum of 3 quarters · filed 2024-08-06 | $858.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $376.00K derived: sum of 2 quarters · filed 2024-06-24 | $555.00K derived: sum of 3 quarters · filed 2024-06-24 | $555.00K 10-K · filed 2024-06-24 |
| 2022-12-31 | $68.00K 10-Q · filed 2024-02-12 | $247.00K derived: sum of 2 quarters · filed 2024-02-12 | $247.00K 10-Q · filed 2024-02-12 | |
| 2022-09-30 | $179.00K 10-Q · filed 2023-11-13 | $179.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |